Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey
Bitting R, McNair C, Wyatt A, Vandekerkhove G, Choi T, Leader A, Blanding-Godbolt J, Gross L, Hamade K, Halabi S, Giri V. Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey. JCO Precision Oncology 2025, 9: e2400821. PMID: 40373262, DOI: 10.1200/po-24-00821.Peer-Reviewed Original ResearchConceptsGenomic testingTraining of health care professionalsHereditary cancer assessmentSomatic genomic testingHealth care providersHealth care professionalsAcademic medical centerLack of educationSelf-confidenceProvider confidenceCare providersCare professionalsCommon barriersSurvey domainsProstate cancerPractical barriersMultiple-response questionsTest utilizationMedical oncologistsMedical CenterEnhanced implementationDecision-making factorsProvidersDecision-makingPercentage of responses
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply